Sorrentino R, de Souza P M, Sriskandan S, Duffin C, Paul-Clark M J, Mitchell J A
Cardiothoracic Pharmacology Department, Unit of Critical Care Medicine, National Heart and Lung Institute, Imperial College, London, UK.
Br J Pharmacol. 2008 Jun;154(4):864-71. doi: 10.1038/bjp.2008.139. Epub 2008 Apr 21.
Lung epithelial cells express pattern recognition receptors, which react to bacteria. We have evaluated the effect of Gram-positive and Gram-negative bacteria on interleukin-8 (CXCL8) release from epithelial cells and the integrity of the epithelial barrier.
Primary cultures of human airway epithelial cells and the epithelial cell line A549 were used, and CXCL8 release was measured after exposure to Gram-negative or Gram-positive bacteria. Epithelial barrier function was assessed in monolayer cultures of A549 cells.
Gram-positive bacteria Staphylococcus aureus or Streptococcus pneumoniae, induced release of CXCL8 from human airway epithelial cells. These bacteria also disrupted barrier function in A549 cells, an effect mimicked by CXCL8 and blocked by specific binding antibodies to CXCL8. Gram-negative bacteria Escherichia coli or Pseudomonas aeruginosa induced greater release of CXCL8 than Gram-positive bacteria. However, Gram-negative bacteria did not affect epithelial barrier function directly, but prevented disruption induced by Gram-positive bacteria. These effects of Gram-negative bacteria on barrier function were mimicked by FK565, an agonist of the nucleotide-binding oligomerization domain 1 (NOD1) receptor, but not by the Toll-like receptor (TLR) 4 agonist bacterial lipopolysaccharide. Neither the Gram-negative bacteria nor FK565 blocked CXCL8 release.
These data show differential functional responses induced by Gram-negative and Gram-positive bacteria in human lung epithelial cells. The NOD1 receptors may have a role in preventing disruption of the epithelial barrier in lung, during inflammatory states.
肺上皮细胞表达可对细菌产生反应的模式识别受体。我们评估了革兰氏阳性菌和革兰氏阴性菌对上皮细胞白细胞介素-8(CXCL8)释放及上皮屏障完整性的影响。
使用人气道上皮细胞原代培养物和上皮细胞系A549,在暴露于革兰氏阴性菌或革兰氏阳性菌后测量CXCL8释放。在A549细胞单层培养物中评估上皮屏障功能。
革兰氏阳性菌金黄色葡萄球菌或肺炎链球菌可诱导人气道上皮细胞释放CXCL8。这些细菌还破坏了A549细胞的屏障功能,CXCL8可模拟此效应,且该效应可被CXCL8特异性结合抗体阻断。革兰氏阴性菌大肠杆菌或铜绿假单胞菌诱导的CXCL8释放比革兰氏阳性菌更多。然而,革兰氏阴性菌并不直接影响上皮屏障功能,但可防止革兰氏阳性菌诱导的屏障破坏。革兰氏阴性菌对屏障功能的这些作用可被核苷酸结合寡聚化结构域1(NOD1)受体激动剂FK565模拟,但不能被Toll样受体(TLR)4激动剂细菌脂多糖模拟。革兰氏阴性菌和FK565均未阻断CXCL8释放。
这些数据显示了革兰氏阴性菌和革兰氏阳性菌在人肺上皮细胞中诱导的不同功能反应。在炎症状态下,NOD1受体可能在防止肺部上皮屏障破坏中发挥作用。